Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer. 2010 Apr 01; 126(7):1630-9.
View in:
PubMed
subject areas
Adaptor Proteins, Signal Transducing
Aged
Antigens, CD
Apoptosis Regulatory Proteins
Cadherins
Calcium-Calmodulin-Dependent Protein Kinases
Carcinoma, Non-Small-Cell Lung
Case-Control Studies
CpG Islands
Cyclin-Dependent Kinase Inhibitor p16
Death-Associated Protein Kinases
DNA Methylation
DNA Modification Methylases
DNA Repair Enzymes
Female
Follow-Up Studies
Humans
Immunoenzyme Techniques
In Situ Hybridization, Fluorescence
Lung
Lung Neoplasms
Male
Middle Aged
Monomeric GTP-Binding Proteins
Neoplasm Proteins
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Promoter Regions, Genetic
PTEN Phosphohydrolase
Survival Rate
Treatment Outcome
Tumor Suppressor Proteins
authors with profiles
Michael Liptay
Philip Bonomi
Mary Jo Fidler